Bullish
Evommune, Inc. Stock 12‑Month Price Target Cut to $39.33, Implies 56% Upside
Evommune, Inc. (EVMN) has seen its average 12-month price target reduced from $45.22 to $39.33 by analysts, though this new target still suggests appr...